2022 annual financial data

Fennec Pharmaceuticals 2022 Net margin

Direct answer

Net margin was -1,544.89%.

Operating income was -22,738,000 USD and net income was -23,714,000 USD.
Operating cash flow was -18,058,000 USD.

Get free Fennec Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,535,000 USD
Operating income
-22,738,000 USD
Net income
-23,714,000 USD
Operating cash flow
-18,058,000 USD